Susceptibility of pentylenetetrazole-induced seizures in mice with Cereblon gene knockout

다국어 초록 (Multilingual Abstract)

Epilepsy is a neurological disorder characterized by unpredictable seizures, which are bursts of electrical activity that temporarily affect the brain. Cereblon (CRBN), a DCAFs (DDB1 and CUL4-associated factors), is a well-established protein associated with human mental retardation. Being a substrate receptor of the cullin-RING E3 ubiquitin ligase (CRL) 4 complex, CRBN mediates ubiquitination of several substrates and conducts multiple biological processes. In the central nervous system, the largeconductance Ca2+-activated K+ (BKCa) channel, which is the substrate of CRBN, is an important regulator of epilepsy. Despite the functional role and importance of CRBN in the brain, direct injection of pentylenetetrazole (PTZ) to induce seizures in CRBN knock-out mice has not been challenged. In this study, we investigated the effect of PTZ in CRBN knock-out mice.
Here, we demonstrate that, compared with WT mice, CRBN knock-out mice do not show the intensification of seizures by PTZ induction. Moreover, electroencephalography recordings were also performed in the brains of both WT and CRBN knockout mice to identify the absence of significant differences in the pattern of seizure activities. Consistently, immunoblot analysis for validating the protein level of the CRL4 complex containing CRBN (CRL4Crbn) in the mouse brain was carried out.
Taken together, we found that the deficiency of CRBN does not affect PTZ-induced seizure.

참고문헌 (Reference)

1 Lupas AN, "The thalidomidebinding domain of cereblon defines the CULT domain family and is a new member of the beta-tent fold" 11 : e1004023-, 2015

2 Zhu Y, "The Yin and Yang of BK channels in epilepsy" 17 : 272-279, 2018

3 Bulatov E, "Targeting Cullin-RING E3ubiquitin ligases for drug discovery : structure, assembly and small-molecule modulation" 467 : 365-386, 2015

4 Pines A, "TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A" 9 : 1040-, 2018

5 Fischer ES, "Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide" 512 : 49-53, 2014

6 Dias J, "Structural analysis of the KANSL1/WDR5/KANSL2 complex reveals that WDR5 is required for efficient assembly and chromatin targeting of the NSL complex" 28 : 929-942, 2014

7 Pedersen TH, "Role of physiological ClC-1 Cl-ion channel regulation for the excitability and function of working skeletal muscle" 147 : 291-308, 2016

8 Jobe PC, "Neurotransmitters and epilepsy" Springer Science & Business Media 1987

9 Robinson SR, "Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes" 36 : 471-482, 2000

10 Schneider CA, "NIH Image to ImageJ : 25 years of image analysis" 9 : 671-675, 2012

11 Angers S, "Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery" 443 : 590-593, 2006

12 Ferraro TN, "Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice" 19 : 6733-6739, 1999

13 Ito T, "Identification of a primary target of thalidomide teratogenicity" 327 : 1345-1350, 2010

14 Jo S, "Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain" 94 : 1212-1224, 2005

15 Nguyen TV, "Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon" 61 : 809-820, 2016

16 Lee KM, "Functional modulation of AMP-activated protein kinase by cereblon" 1813 : 448-455, 2011

17 Bozzi Y, "Epilepsy as a neurodevelopmental disorder" 3 : 19-, 2012

18 Kang JA, "Epigenetic regulation of Kcna3-encoding Kv1. 3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation" 113 : 8771-8776, 2016

19 Mates JM, "Dysregulation of glutaminase and glutamine synthetase in cancer" 467 : 29-39, 2019

20 Lee KM, "Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice" 62 : 1855-1864, 2013

21 Harai T, "Decreased susceptibility to seizures induced by pentylenetetrazole in serine racemase knockout mice" 102 : 180-187, 2012

22 Lee J, "DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase" 26 : 775-780, 2007

23 Han Y, "Characterization of RING finger E3-ubiquitin ligase cereblon in hematopoietic regulation" 122 : 1207-1207, 2013

24 Choi TY, "Cereblon maintains synaptic and cognitive function by regulating BK channel" 38 : 3571-3583, 2018

25 Hohberger B, "Cereblon is expressed in the retina and binds to voltage-gated chloride channels" 583 : 633-637, 2009

26 Lopez-Girona A, "Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide" 26 : 2326-2335, 2012

27 Shi Q, "Cereblon : a protein crucial to the multiple functions of immunomodulatory drugs as well as cell metabolism and disease generation" 2017 : 9130608-, 2017

28 Liu J, "CRL4A(CRBN)E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis" 5 : 3924-, 2014

29 Wu C, "BioGPS : an extensible and customizable portal for querying and organizing gene annotation resources" 10 : 1-8, 2009

30 Hansen SL, "Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice" 28 : 105-113, 2004

31 Higgins JJ, "A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation" 63 : 1927-1931, 2004